Simcere Pharmaceutical Group Limited’s HK$3.57 Billion IPO

O’Melveny & Myers LLP advised Simcere Pharmaceutical Group Limited on the deal. Herbert Smith Freehills has advised Morgan Stanley Asia Limited and China International Capital Corporation…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Michael Patrini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here